To assess the role of different types of antigen-presenting cells (APC) in the induction of tolerance, we isolated B cells, macrophages, and dendritic cells from thymus and spleen, and injected these into neonatal BALB/c mice across an Mls-1 antigenic barrier. One week after injection of APC from Mls-I-incompatible mice or from control syngeneic mice, we measured the number of thymic, Mls-1'-reactive, Vs6+ T cells and the capacity of thymocytes to induce a graft-vs .-host (GVH) reaction in popliteal lymph nodes of Mls-1' mice. Injection of thymic but not spleen B cells deleted thymic, Mls-1'-reactive Vs6+ T cells and induced tolerance in the GVH assay. The thymic B cells were primarily of the CD5+ type, and fluorescence-activated cell sorter-purified CD5+ thymic B cells were active. Injection of dendritic cells from spleen or thymus also induced tolerance, but the Vs6 cells were anergized rather than deleted . Macrophages from thymus did not induce tolerance. Dendritic cells and thymic B cells were also effective in inducing tolerance even when injected into Mls -, major histocompatability complex-incompatible, I-E -mice, but only thymic B cells depleted V06-expressing T cells . Therefore, different types of bone marrowderived APC have different capacities for inducing tolerance, and the active cell types (dendritic cells and CD5+ thymic B cells) can act by distinct mechanisms .
O ne of the important functions of the thymus gland is to inactivate lymphocytes that would react against selfconstituents (1) . Tolerance can develop in at least two ways: clonal deletion (2) (3) (4) (5) and clonal anergy (6) (7) (8) . The latter refers to a phenomenon whereby self-reactive T cells are present but are unable to make an effective response to antigen. T cells expressing both x/,6 and y/S types of TCR can be tolerized in the thymus (9-13). There is evidence that thymic APC derived from the bone marrow are somehow important in bringing about tolerance (12, 14) , one such model being the induction of tolerance to an antigen called Mls (15) . Mls is an attractive model since specific TCR Vs genes encode reactivity to specific alleles of Mls, enabling one to enumerate Mls-reactive T cells (3, 5) .
We have noted that the mouse thymus contains a small number of B cells, the majority of which express the CD5 molecules (16) . B cells are known to be the major type of APC that express MIS (17) (18) (19) . We have now prepared highly enriched populations of B cells from thymus and spleen and injected these into the thymi of mice at the neonatal period, when mice are most susceptible to the induction of tolerance (20) (21) (22) . We find that B cells from thymus, including those bearing CD5, and activated B blasts, but not resting spleen B cells, can induce tolerance by deleting Mls-reactive T cells. When other APC are tested, dendritic cells but not macrophages also can tolerize to Mls, but the dendritic cells do so by inducing clonal anergy rather than deletion.
Materials and Methods
Mice. Mice with different MIS and MHC antigens were obtained from Japan SLC; Shizuoka and Clea Japan ; Osaka, Japan . The strains were DBA/2,H-2d, Mls-1'; BALB/c, H-2d, Mls-16 ; BALB/c x DBA/2 F, (CxD2 F,), H-2d, Mls-lbia; C57BL/6, H-2b, Mls-1b, C57BL/6 x DBA/2 (B6xD2 F,) H-2b/d, Mls-11/2; BALB/c x C57BL/6 (CxB6 F,), H-2d/b, Mls-1b ; C3H/He, H-2t, Mls-I" ; B6.H-2t, H-2t, Mls-l"; and AKR/J, H-2E, Mls-1' .
APC. Dendritic cells and thymic B cells were prepared as described elsewhere (16, 23) . These APC were >98% Ig -and >95% Ig', respectively, and lacked detectable macrophages stained with F4/80 mAb. Briefly, dendritic cells were prepared from collagenase-digested organs that were centrifuged in dense BSA columns to provide low-density adherent populations. After over-night culture, dendritic cells became nonadherent, while macrophages remained adherent but could be dislodged after 30 min of culture in PBS with 1 mM EDTA at 37°C. In some experiments, dendritic cells were further purifiedby treatment with anti-B cell mAb (RA3-3A1/6 .1;TIB146 or J11d .2;TIB183) plus rabbit complement. Depletion of B cells was monitored by the absence of mitogen responses to LPS. Positive selection of dendritic cells was performed by sorting as N418' (24) cells using a FACStar Plus* (Becton Dickinson & Co., Mountain View, CA) according to method described (25) . Thymic B cells were prepared from teased thymi that were centrifuged in dense Percoll columns to provide a low-density population . The low-density fraction from the teased thymi had only trace levels of dendritic cells, and was depleted of T cells by treatment with a mixture of antiThy-1.2 (HO-13-4), CD4 (GK1.5), and CD8 (HO-2.2 and 3.155) mAb and complement . Anti-CD5 mAb (C3PO; American Type Culture Collection, Rockville, MD) was used to deplete CD5' B cells (N75% of the total) in the thymic B cell population, while biotinylated anti-CD5 and PE-avidin (Becton Dickinson & Co .) were used to sort the CD5' B cells on a FACStar instrument (Becton Dickinson & Co.) . Splenic B cells were Sephadex G-10 nonadherent cells depleted of T cells by antiThy-1.2 mAb and complement, followed by Percoll density gradient centrifugation to obtain high-density resting B cells. Splenic B cells cultured for 24 h with goat F(ab')2 anti-mouse IgM Ab (Tago Inc., Burlingame, CA) plus murine IL-4 served as B blasts .
Neonatal Tolerance Regimen to Mis, and Frequency of Mls-reactive T Cells. BALB/c Mls-lb newborn mice within 24 h of birth were anesthetized with diethyl ether and fixed onto a boardwith rubber bands. The mediastinum was opened and 0.5 pl of an APC cell suspension (5 x 105 ) was injected directly into each lobe of the thymus using a 5-pl microsyringe. The APC were from incompatible Mls-1' or from syngeneic Mls-lb mice . The chest was then closed by suturing the overlaying skin. 1 wk later, the thymus or pooled peripheral lymph nodes (axillary, inguinal, brachial, mesenteric) were removed and tested for Mls reactivity (below) or for the frequency of cells expressing different TCR Vs antigens by FACScan and Consort 30 program (Becton Dickinson & Co.) . The antiV06 and antiVs8 mAbs were rat 44-22-1 and mouse F23.1, respectively, and these were visualized with FITC mouse anti-rat Ig (Boehringer Mannheim Biochemicals, Indianapolis, IN) and goat anti-mouse Ig (Cappel Laboratories, Malvern, PA). As will be evident in the results, antiVs6 cells were tolerized while most Vs8 cells were not, even though some V,s8 .1 cells are Mls-1' reactive (3).
Responses to Mls In Viva Different APC, including CD5' B cells enriched by sorting thymic B cells on a FACStar after staining with biotinylated anti-CD5 plus PE-avidin mAb (26) , were injected intrathymically into BALB/c neonatal mice. 1 wk later, reactivity of these tolerized cells to Mls-1' in vivo was assessed by injecting 2 x 10' thymocytes in 25 td into the hind footpad of adult mice that were disparate at Mls-1' or MHC loci or at both loci . Lymph node swelling as a measure of a local graft-vs .-host reaction (GVHR)' was performed 7 d later (27) . Percent responsiveness was calculated according to the formula: 100x ((lymph node weight in experimental mouse -the mean weight in negative control)/(the mean weight in positive control -the mean weight in negative control)] . The positive controls were given thymocytes from BALB/c mice and the negative controls were given thymocytes from agematched syngeneic CxD2 mice . This assay may measure tolerance to Mls' as well as tolerance to other histocompatibility differences between BALB/c and DBA/2.
'Abbreviation used in this paper: GVHR, graft-vs .-host reaction . Responsiveness to immobilized anti-V#6, antiVg8 and anti-CD3 mAb was measured by proliferation of B cell-depleted lymph node cells (axillary, brachial, and mesenteric nodes) obtained from mice that were injected intrathymically with APC 9 d before . The anti-V06, anti -V08, and anti-CD3 mAbs in culture supernatant were fixed onto tissue culture plates by 50,ug/ml of goat anti-rat IgG, anti-mouse IgG, and anti-hamster IgG, respectively. Results are the means of duplicate cultures.
Results
Presentation of Mls Antigens by Thymic B Cells and Other APC. We first compared the capacity of CD5+ B As and dendritic cells from the thymus to present Mls alloantigens to T cells in vitro, since this had not been studied previously. CD4+ T cells were used as responders, since the bulk of the (18) . In contrast to previous results, however, it appeared that thymic and spleen dendritic cells could present Mls antigens. Specifically, we found that T cells proliferated more actively when there was an Mls disparity expressed by the dendritic cell (CxD2-stimulating BALB/c) than when there was no such disparity (BALB/c-stimulating BALB/c) ( ,000 dendritic cells were used to stimulate 300,000 CD4+ T cells, the cultures were harvested and stained with rat mAb followed by FITC mouse anti-rat Ig. The rat mAb are listed at the top and include a nonreactive control (RB6 antigranulocyte), anti-CD4 (GK1 .5), antiVp8 (KJ16), and antiVo6 (44-22-1). Dead cells and debris were gated out on the basis of propidium iodide-staining and low forward light scatter. Shown here are the data on live cells comparing fluorescence (y-axis, four decates) and forward light scatter (x-axis) as a measure of cell size. The arrows denote the location of small unstimulated lymphocytes, while to the right of the arrow are found the enlarged blasts. To show that the blasts were responding to dendritic cells, the cultures were separated into cluster and noncluster fractions, since most of the dendritic cells and blasts are found in large aggregates as described (44) . Note that most of the large blasts are found in the cluster fraction when either Mls or MHC is the stimulus (e.g., open arrow) . However, in the case of Mls, the majority of the blasts express the Mls-1-reactive TCR, V06, whereas in the case of MHC, the frequency of V06 blasts is low and comparable with unstimulated T cells (latter not shown) .
and A vs. " ]) . APC from both CxD2 and BALB/c mice actively stimulated CD4+ T cells from MHC-incompatible C57BL/6 mice ( Fig . 1 B) . It is possible that the proliferation of T cells that was induced by dendritic cells was due to a small contamination of Ig+ B cells in the dendritic cell population . However, B cell-depleted purified dendritic cell preparations were comparably effective in stimulating Mls-disparate T cells to conventional FcR -dendritic cell preparation ( (Fig . 4 A) . Dead cells were gated out by the staining with ethidium bromide.
In addition, positively selected cultured N418+ (CD11c+) dendritic cells (25) from the spleen and the thymus were also a potent stimulator for Mls-disparate CD4+ T cells ( That the stimulating antigens on dendritic cells were in fact Mls was also evidenced by the finding that -55% of the enlarged T blasts induced by Mls-disparate CxD2 dendritic cells expressed the Vj36 gene that confers Mls reactivity, whereas only -13% of the blasts were positive after stimulation with MHC-incompatible dendritic cells (Fig. 2 and Table 2 ) . Therefore, stimulation with Mls selectively expands T cells expressing V06, while stimulation with MHC does not expand these cells above their normal frequency. Only a slight increase in the frequency of V08+ blasts was observed after stimulation by Mls-disparate dendritic cells relative to allogenic dendritic cells (Table 2 ). This result suggests. that V06+ T cells are the major cell type responding to Mls-1' antigen, although some V08 .1, 7, and 9 T cells can also be reactive from work in other laboratories. Similar results were obtained in Mls-MLR using thymic dendritic cells, thymic B cells, and splenic B blasts. We therefore conclude that thymic B cells, splenic B blasts, and both thymic and spleen dendritic cells can carry Mls antigens in a stimulatory form.
Thymic B Cells Induce Neonatal Tolerance by a Deletional Mechanism . We proceeded to inoculate both lobes of neonatal thymi with populations of thymic and splenic B cells and dendritic cells. The injected APC were from CxD2 F1 mice (Mls-1'), or from syngeneic BALB/c as controls, and the neonates were 0-1-d-old BALB/c , so that we could monitor the frequency of V#6-bearing T cells that responded to-Mls-1 2 . We evaluated the thymi at day 7 when Lymph node cells from axillary, inguinal, brachial and mesenteric nodes were obtained from individual mice and depleted of B cells by the treatment with mAb (TIB146 ; anti-B220) plus complement . Responsiveness to immobilized anti-Vp6, anti-VO8, and anti-CD3 was assessed in vitro . Proliferation was measured by [3H]TdR incorporation of 3 x 105 cells at 68-72 h for anti-V06 and anti-V,98 mAbs and at 34-48 h for anti-CD3 mAb . Results represent the mean of duplicate cultures . V06 expression of T cells was also monitored by FACScan, as described in Fig . 2 . control BALB/c thymocytes included 5 .6% V061°"' and 1 .3% Vo6h'g h T cells (Fig. 3 A) . When the BALB/c thymi had been injected with CxD2 thymic B cells, however, there was virtually a complete deletion of both V06h'gh and V061°"' (Fig. 3 B) . Moreover, the intrathymic injection of BALB/c thymic B cells did not affect the V#6 expression of thymocytes (not shown) . Injections of resting B cells from spleen, and dendritic cells from spleen or thymus, did not delete thymocytes expressing Vs6 (Fig. 3, C-E) . Therefore, thymic CD5+ B cells can delete self-reactive T cells in neonatal thymi, but dendritic cells cannot .
To pursue tolerance at the functional level, we relied on an in vivo approach . An in vitro assay was not used, since it is difficult to induce a significant proliferative response to Mls-1' in thymocytes. This is presumably because the number of CD4+, V,66+ cells is so small . However, it is known that thymocytes can induce an anti-Mls response in vivo in the form of a local GVHR, in which T cells injected into the footpad lead to the enlargement of the draining popliteal lymph node (27) . The thymocytes from newborn BALB/c mice given intrathymic inoculation of CxD2 Mlsincompatible APC were therefore injected into the footpads of CxD2 mice to examine the reactivity to Mls. As expected, when bulk thymic B cells or purified CD5+ thymic B cells had been injected into the thymi, the thymocytes lacked Mls-1'-reactive cells and did not induce GVH (Fig. 4 A) . However, no change of reactivity to third-party allogenic MHC antigen was observed . Treatment of thymic B cells with anti-CD5 mAb and complement depleted some but not all of the tolerizing activity. This may indicate a role for CD5 -thymic cells, or a lack of complete killing of the active CD5+ component. If bulk populations of splenic B cell were injected, the change of Vs6 expression and reactivity to Mls-la was slight (Fig. 4, A and C) . High-density resting spleen B cells induced neither a change of V06 expression nor tolerance to the Mls product (Fig. 4 C) . Like thymic B cells, however, activated spleen B blasts deleted V#6-expressing thymocytes, resulting in a lack of reactivity to Mls (Fig. 4 C) . Dendritic Cells Induce Neonatal Tolerance to Mls via Clonal Anergy. As shown above, splenic dendritic cells did not induce clonal deletion in neonatal mice, but surprisingly, these APC did induce functional tolerance. No local GVHR was observed using T cells from thymi that had been injectedwith dendritic cells, in spite of the presence of cells expressing Vs 6 (Fig. 4 B) . This indicates that dendritic cells can induce tolerance, but the mechanism is likely to be clonal inactivation rather than deletion .
To verify that the Va6+ cells in dendritic cell-tolerated mice are anergic, we tested their responsiveness to stimulation with mAb to Vs6 and other TCR epitopes (Table 3) . The lymph node cells from tolerant animals were indeed hyporesponsive to antiVs6 but were normally responsive to anti-CD3 and Vs8 .
To compare other types of bone marrow-derived thymic APC with B cells, we injected thymic dendritic cells or macrophages into neonatal thymi (Fig. 4 B) . Only the dendritic cells tolerized the mice, and as in the case of spleen dendritic cells, Vs6 cells were not deleted . It is important to recall that to obtain thymic dendritic cells and macrophages, it is necessary to use collagenase-digested thymi (23) , whereas thymic B cell isolates are obtained from teased thymi and have few other types of APC (16) .
Direct Effect of Thymic B Cells on the Deletion of V#6+ T Cells in Association with MHC Antigen. Deletion of Vs6+ T cells in the thymus is known to require the expression of MHC class II I-E molecules (14, 29, 30) . To examine the possibility that elimination of Vs6+ T cells by thymic CD5+ B cells was due to the transfer of the Mls product to host thymic dendritic cells, we injected thymic B cells or
Dendritic cell
Groups of four to seven neonatal mice were given an intrathymic injection of 5 x 105 APC per lobe. Responsiveness of the thymocytes to and MHC antigens at 1 wk after injection was measured by lymph node swelling in local GVHR. All the data are given in terms of percent of the positive control value using thymoctyes from uninjected mice. The values of lymph node weight in five mice as positive and negative controls were 2 .98 ± 0 .18 and 0 .97 ± 0.15 mg in BALB/c mice, 3 .12 ± 0.23 and 1 .06 ± 0 .12 mg in CxD2 mice, 3 .03 ± 0.18 and 0 .89 ± 0 .17 mg in B6xD2 mice and 3 .48 ± 0 .31 and 1 .23 *-0.14 mg in AKR mice (Exp . 1); and 3 .02 ± 0 .18 and0 .99 ± 0 .12 mg in C57BL/6 mice, 2 .88 ± 0 . Ontogeny of Thymic CD5+ B Cells and Mls-reactive T Cells in Thymi . To assess if CD5+ B cells might delete Mls-1a-reactive T cells during normal thymus development, we monitored the numbers of Vs6+ T cells and CD5+ B cells during the first week of life in Mls-1a mice, since it is known that Vs6+ cells appear transiently (31) . In fact, the numbers of CD5+ B cells began to increase just at the time the Vs6+ cells began to decrease or be deleted (Fig . 5) . In a separate experiment, we obtained the following data by teasing a thymic lobe ; 1.3-1 . The thymocytes from 4-d-old CxD2 mice already showed a 65-90% reduced response to Mls-la antigen, when assessed by local GVHR. Almost no reactivity to Mls-la was detected in thymocytes at day 7, as in the case of adult CxD2 mice (not shown) . We next compared the appearance of Vs6wgb and Vp610 W T cells between CxD2 at various ages and BALB/c injected with graded dose of thymic B cells (Fig. 6) . A low dose of thymic B cells induced a slight reduction of V#6b'ge, but not V#6 1°-, T cells (Fig . 6 B) . A medium dose of B cells considerably deleted not only V# 6b'g6 but also V#6 1-T cells (Fig. 6 C) . On the other hand, the percentages of Vg6b'g6 and V#61 ow T cells in CxD2 at 7 d were less than those in age-matched BALB/c (Fig. 6 , H vs. A), and both decreased gradually with age (Fig. 6, G-J) . Finally, only a small number of V061°W T cells remained in the thymus in the adult mouse (Fig. 6 , J vs. E).
Discussion
It has been demonstrated by Mazinger and Guerder (32) that dendritic cells from spleen abrogate the generation of cytotoxic T cells in fetal thymus in vitro, indicating that the dendritic cells, the most potent activator for peripheral T cells, are also potent in the inactivation of developing T cells. The experiments presented here examine a wider range of APC and provide evidence that different types of thymic APC can have different roles in the establishment of tolerance : thymic B cells tolerize by a deletion mechanism ; thymic dendritic cells tolerize by inducing anergy ; and thymic macrophages are inactive. Deletion also was observed with splenic B blasts but not resting B cells . Like thymic dendritic cells, spleen dendritic cells induce anergy, while splenic macrophages are inactive.
Mls, which has not been identified biochemically, is a cellassociated antigen that is expressed gradually on B cells (17) (18) (19) . Dendritic cells did not express detectable Mls previously (17, 18) , whereas our results here show that both thymic and splenic dendritic cells can express Mls-1', as reported by Sunshine et al . (33) . Mls-13-specific T cell proliferation induced by dendritic cells is not due to B cells that contaminate the dendritic cell preparation, since B cell depletion did not affect the stimulatory activity of dendritic cells, and highly purified N418+ dendritic cells also induced T cell proliferation to Mls-1'. This discrepancy may be ascribed to the difference of mouse strains or to the method of assay. In our case, we used CxD2 mice and monitored V#6+, Mls-1'-reactive blasts directly.
Hengartner et al . (34) have documented that T cells bearing TCR with self-reactivity are present at high density in the thymic cortex but not in the medullary region . This strengthens the idea that the deletion of self-reactive T cells takes place at the cortico-medullary junction, where bone marrow-derived dendritic cells are localized (35, 36) . However, our results show that dendritic cells injected intrathymically do not induce deletion of self-reactive T cell clones. Considering that thymic B cells are detected throughout the thymus (37) and that Mls antigens are a product of activated B cells (17, 18) , it may well be that the dendritic cell only acquires small amounts of Mls antigens during their preparation as a result of transfer from thymic B cells or spleen B cells (14) . This idea seems to be compatible with the result that fresh N418+ thymic and spleen dendritic cells are equally potent in stimulating MHC-incompatible T cells, but thymic dendritic cells are much less effective in inducing Mlsdisparate T cell proliferation than spleen dendritic cells. Larger amounts of Mls antigens on dendritic cells, which might be produced by injected thymic B cells, may lead to deletion rather than anergy. This possibility remains to be elucidated .
The mechanism of clonal deletion by thymic B cells or splenic B blasts injected intrathymically is so far not clear. The APC might directly interact with developing T cells in cortex or medulla. Both dendritic cells and B cells in the thymus are detected at 14 d of gestation (38) (39) (40) (41) (42) . B cells increase in number after birth by day 7. Preceding this, the number of Vs6+ T cells in the CxD2 mouse reaches a maximum at day 3-4 and then decreases. These results seem to support the idea that Mls products secreted by thymic B cells are taken up by dendritic cells, and then, Mls-reactive T cells are clonally deleted . It has been documented that tolerance to Mls results from the selective depletion of Vs6high T cells (34) , and that the class II I-E molecules are required for the presentation of the Mls-1' product to V06-expressing T cells in the thymus (29, 30) . However, thymic B cell-induced tolerance was accompanied by the deletion of not only Vs6high but also V06 10-expressing T cells . A similar phenomenon was observed even when thymic B cells were injected into Mls-1' -, I-E -C57BL/6 mice. In addition, a low dose of thymic B cell induced the incomplete but preferential decrease of Vs6high T cells, whereas a medium dose significantly reduced both Vo6high and Vo6l°"' cells. This was also the case when CxD2 thymic B cells were injected into neonatal C57BL/6 thymi (data not shown) . Therefore, our conclusion for the time being is that thymic B cells by themselves can, after intrathymic injections, directly interact with developing V,361°"'-positive T cells and delete them.
Recently, Webb and Sprent (43) reported that CD8+ T cells play a role in the clonal deletion of Mls-reactive T cells in the thymus . They inoculated the cells into newborn mice intravenously via the facial vein . Small numbers of injected cells migrated into the thymus, and the tolerant state lasted for >7 wk. We cannot exclude the possibility that small numbers of CD8+ T cells contaminate our preparation of dendritic cells or thymic B cells. Unlike their report, however, thymic dendritic cells or B cells injected intrathymically induced temporary tolerance that lasted only 9-10 d and was not detectable at 14 d both in the thymus and in lymph nodes (data not shown) . Therefore, dendritic cells and B cells, which express the class II MHC molecules needed to present Mls, may differ in the mechanism of tolerance induction from CD8+ T cells that do not express class II.
The direct, neonatal intrathymic injection protocol described here may prove useful in delineating the role of specific types of APC in the induction of self-tolerance . A role of thymic B cells, including CD5+ B cells, might be considered in further analyses of this important area of thymus physiology. Our results apply to the widely studied Mls-1°antigen, and need to be extended to other antigens.
